Clinical Trial Update: Study of Immune Thrombocytopenia Pathogenesis:

View source ↗

Summary

A trial investigating the pathogenesis of immune thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Primary Immune Thrombocytopenia (ITP) | Status: COMPLETED